AVAleksandr Voskoboinik

Aleksandr Voskoboinik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aleksandr Voskoboinik has a total of 190 co-authors. Here are the top co-authors by number of shared publications:

  • Peter Merrick Kistler

    The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne, Australia; Cabrini Malvern Hospital, Melbourne, Australia

    19 shared publications
  • Sandeep Prabhu

    13 shared publications
  • Hariharan Sugumar

    The Baker Heart and Diabetes Research Institute, Melbourne, Australia (L.S., D.C., H.S., L.-H.L., S.A., Z.N., A.V., P.M.K., S.P.).

    10 shared publications
  • Jonathan M. Kalman

    University of Melbourne, School of Medicine, Melbourne, Victoria, Australia; Royal Melbourne Hospital, Department of Cardiology, Melbourne, Victoria, Australia

    10 shared publications
  • Peter M. Kistler

    10 shared publications
  • Jeremy William

    Monash University, School of Translational Medicine, Melbourne, Victoria, Australia; The Baker Heart and Diabetes Institute, Electrophysiology Lab, Melbourne, Victoria, Australia; The Alfred Hospital, Department of Cardiology, Melbourne, Victoria, Australia

    7 shared publications

Latest Publications

  • Very late recurrence after atrial fibrillation ablation: Clinical characteristics and pulmonary vein reconnection patterns

    by Jeff R. Ma, Bruno Scardamaglia Kistler, Rose Crowley, Louise Segan, David Chieng, Hariharan Sugumar, Sandeep Prabhu, Liang-Han Ling, Peter M. Kistler, Aleksandr Voskoboinik

  • Sex‐Based Differences in Atrial Fibrillation: Epidemiology, Prehospital Care, Hospital Management, and Outcomes

    by Malanka Lankaputhra, Emily Mahony, Emily Nehme, Luke P. Dawson, Aleksandr Voskoboinik, Riley Batchelor, Vishal Goel, Mark Horrigan, Joseph Hogarty, Tegwyn McManamny, et al.

    Background: Atrial fibrillation is a leading cause of emergency medical services (EMS) use, but sex differences across prehospital, hospital, and postdischarge care remain poorly characterized. Methods: We performed a population‐based linked cohort study of adults attended by EMS for atrial fibrillation in Victoria, Australia, from January 1, 2015, to June 30, 2019. EMS records were linked to emergency department, hospital admission, and death data sets. Multivariable models evaluated sex differences in care and outcomes. Results: Among 16 415 atrial fibrillation EMS attendances, 9329 (56.8%) were in women, median age 76 years. Age‐standardized attendance rates were higher in women (77 versus 57 per 100 000 person‐years; incidence rate ratio, 1.35 [95% CI, 1.33–1.38]), especially in metropolitan areas and adults aged ≥70 years. Women had lower odds of prehospital treatment (56% versus 62%; adjusted odds ratio [aOR], 0.85 [95% CI, 0.79–0.92]) and mobile intensive care paramedic attendance (aOR, 0.85 [95% CI, 0.78–0.93]). Presentation‐conditioned aspirin and appropriate analgesia did not differ by sex. Women had fewer cardioversions (aOR, 0.79 [95% CI, 0.70–0.89]) but similar ablation rates (aOR, 0.95 [95% CI, 0.83–1.10]), higher 30‐day and 6‐month EMS reattendance (adjusted hazard ratios [aHRs], 1.29 and 1.35), and lower 30‐day and long‐term mortality (aHRs, 0.83 and 0.71). Conclusions: Women attended by EMS for atrial fibrillation had lower global prehospital treatment, higher reattendance, and lower mortality than men, supporting standardized prehospital pathways and rapid‐access follow‐up.

  • Young-Onset Atrial Fibrillation

    by Nicholas W. D’ELia, Mariana Dragas, Frank Bevacqua, Dylan Jape, Romaniya Fernando, Kenneth Cho, Jeremy William, Rose Crowley, Sachin Iyer, Sandeep Prabhu, et al.


  • Long-Term Outcomes of Dose-Stratified Direct Oral Anticoagulants in Atrial Fibrillation—Results From the Alfred-AF Registry

    by Nicholas D’ELia, Frank Bevacqua, Mariana Dragas, Sandeep Prabhu, Hariharan Sugumar, David Chieng, Louise Segan, Liang Han Ling, Kenneth Cho, Jeremy William, et al.

  • Open Access

    Prevalence of cardiac fibrosis and infiltrative cardiomyopathy in patients with advanced conduction system disease

    by Jeremy William, Haider Muthana, Joseph Hogarty, Andrew Taylor, James L. Hare, Justin Mariani, Hitesh Patel, Geoff Wong, Dion Stub, David M. Kaye, et al.

    Background: Conduction system disease may represent an early manifestation of underlying structural heart disease, including infiltrative disorders. Timely diagnosis of underlying cardiomyopathy has significant implications for clinical management, guiding both disease‐modifying medical therapy and decisions around device implantation. Objective: We sought to investigate the utility of cardiac magnetic resonance imaging (CMR) in patients with conduction system disease and preserved LV function on echocardiography. Methods: We evaluated all patients undergoing CMR between 2005 and 2023 at our institution for the investigation of advanced conduction system disease (complete heart block, Mobitz II block, or bifascicular block). We excluded patients with known systolic heart failure (LVEFn = 19, 16%), of whom only five (26%) had known extracardiac sarcoid prior to CMR. Cardiac fibrosis was observed in a similar proportion of patients across the three subtypes of conduction disease studied ( p = 0.47). Conclusion: Cardiac fibrosis is present in a substantial proportion of patients undergoing CMR for the investigation of conduction disease, even when LV function appears preserved on echocardiography. Cardiac MRI may be an important adjunctive tool for the investigation of conduction disease, particularly in younger patients.

  • Open Access

    Binge drinking and arrhythmias: a sobering message

    by Nicole Evans, Aleksandr Voskoboinik

    Effects of binge drinking. HRV, heart rate variability; ERP, effective refractory period; PV, pulmonary vein; JNK-2, c-Jun N-terminal kinase 2


  • Association between temperature and air pollutants with atrial fibrillation presentations to emergency departments

    by Luke P. Dawson, Jocasta Ball, Andrew Wilson, Lance Emerson, Aleksandr Voskoboinik, Ziad Nehme, Mark Horrigan, David Kaye, Dion Stub

    Introduction: Understanding the impact of environmental exposures on disease incidence is important for environmental guidelines, health services management, and advising patients. We aimed to assess the relationship between daily mean temperature and common pollutants with atrial fibrillation (AF) presentations to emergency departments (EDs).Methods: The study included consecutive adult patients presenting with AF to EDs from 1/1/2014 to 31/12/2020 with linkage to hospital and emergency discharge diagnosis data. A time series quasi‐Poisson regression with a distributed lag nonlinear model was fitted to assess the association between AF with mean air temperature and five common pollutants, overall and according to sex and region, with adjustment for season, day of the week, long‐term trend, and co‐pollutants.Results: In 82 575 AF presentations to EDs during the study period, mean (standard deviations [SD]) (SD) age was 69.6 (SD 14.7) years and 50.7% were female. AF presentations were associated with elevated levels of Particulate Matter (PM) 2.5 (≥57.7 µg/m3) and nitrous dioxide (NO2) (≥16.5 parts per billion), but not mean air temperature or other pollutants (carbon monoxide, sulphur dioxide, or ozone). The attributable fraction of AF presentations relating to above optimal NO2 and PM 2.5 levels was 7.24% and 3.81% resulting in 854 and 450 annual excess AF presentations, respectively.Conclusions: High levels of NO2 and PM 2.5 are associated with increased risk of AF presentations to EDs. These findings have important implications for environmental policies and advice to patients susceptible to AF presentations to EDs, especially in regions with higher baseline levels of PM 2.5 or NO2.


  • Open Access

    Prehospital factors predicting mortality in patients with shock: state-wide linkage study

    by Amminadab L Eliakundu, Jason E Bloom, Jocasta Ball, Emily Nehme, Daniel Okyere, Stephane Heritier, Aleksandr Voskoboinik, Luke Dawson, Shelley Cox, David Anderson, et al.

    Background Patients with shock treated by emergency medical services (EMS) have high morbidity and mortality. Knowledge of prehospital factors predicting outcomes in patients with shock remains limited. We aimed to describe the prehospital predictors of mortality in patients with non-traumatic shock transported to hospital by EMS. Method This is a retrospective cohort study of consecutive ambulance attendances for non-traumatic shock in Victoria, Australia (January 2015–June 2019) linked with government-held administrative data (emergency, admissions and mortality records). Predictors of 30-day mortality were assessed using Cox proportional regressions. The primary outcome was 30-day all-cause mortality. Results Overall, 21 334 patients with non-traumatic shock (median age 69 years, 54.8% female) were successfully linked with state administrative records. Among this cohort, 9 149 (43%) patients died within 30-days. Compared with survivors, non-survivors had a longer median on-scene time: 60 (35–98) versus 30 (19–50), p Conclusion The 30-day mortality from non-traumatic shock is high at 43%. Independent predictors of mortality included age, prehospital cardiac arrest and endotracheal intubation. Interventions that target reversible causes of short-term mortality in patients with non-traumatic shock are a high priority.


  • Predictors of Late Atrial Fibrillation Recurrence After Cardiac Surgery

    by Jeremy William, Kate Rowe, Joseph Hogarty, Xiaoman Xiao, Anita Shirwaiker, Jason E. Bloom, Silvana Marasco, Adam Zimmet, Christopher Merry, Justin Negri, et al.